Transcontinental Inc. announces its results for Fiscal 2016

Transcontinental Inc. announces its results for Fiscal 2016

MONTREAL, QUEBEC — (Marketwired) — 12/06/16 — Fiscal 2016 HighlightsTranscontinental Inc. (TSX: TCL.A)(TSX: TCL.B) announces its results for fiscal 2016, which ended October 31, 2016."I am very proud of our 2016 results", said Francois Olivier, President and Chief Executive Officer of TC Transcontinental. "We successfully continued the transformation of TC Transcontinental while recording the highest adjusted net earnings attributable to shareholders of the Corporation in the

Transcontinental Inc. Amends its Normal Course Issuer Bid

Transcontinental Inc. Amends its Normal Course Issuer Bid

MONTREAL, QUEBEC — (Marketwired) — 12/06/16 — Transcontinental Inc. (TSX: TCL.A)(TSX: TCL.B) received approval from the Toronto Stock Exchange to amend its normal course issuer bid ("NCIB") in order to increase the maximum number of Class A Subordinate Voting Shares that may be repurchased from 1,000,000 Class A Subordinate Voting Shares, representing 1.6% of the 63,513,472 issued and outstanding Class A Subordinate Voting Shares as of April 4, 2016 (the reference date for the NCI

BAYER Canada and DIAGNOS join efforts against Diabetes

BAYER Canada and DIAGNOS join efforts against Diabetes

BROSSARD, QUEBEC — (Marketwired) — 12/06/16 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in applying Artificial Intelligence in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a pilot project contract for diabetic macular edema and diabetic retinopathy screening with BAYER Canada. Under the terms of the agreement, DIAGNOS will provide a fully turn-k